Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
12.79
+0.33 (2.65%)
Dec 20, 2024, 4:00 PM EST - Market closed

DAWN Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-84.29-188.92-142.18-70.65-40.51-12.63
Depreciation & Amortization
1.370.380.530.20.16-
Asset Writedown & Restructuring Costs
553-8--
Loss (Gain) From Sale of Investments
-5.14-10.08-2.03---
Stock-Based Compensation
48.0439.3427.2413.320.530.11
Other Operating Activities
-108---2.1126.697.56
Change in Accounts Payable
-0.372.32-1.481.540.130.01
Change in Other Net Operating Assets
10.787.18.051.15-0.490.43
Operating Cash Flow
-89.48-146.85-109.87-48.54-13.49-4.52
Capital Expenditures
-0.76-0.22-0.03--0.09-
Sale (Purchase) of Intangibles
-72.1-3--8--
Investment in Securities
33.88131.6-255.05---
Investing Cash Flow
69.03128.38-255.07-8-0.09-
Long-Term Debt Issued
-----1
Net Debt Issued (Repaid)
-----1
Issuance of Common Stock
181.1164165.9167.36--
Financing Cash Flow
202.04164165.9297.1229.9830.91
Net Cash Flow
181.59145.52-199.05240.5816.426.39
Free Cash Flow
-90.24-147.08-109.9-48.54-13.58-4.52
Free Cash Flow Per Share
-1.01-1.84-1.68-1.31-2.46-0.76
Levered Free Cash Flow
-151.71-82.72-56.86-37.01-9.6-
Unlevered Free Cash Flow
-151.71-82.72-56.86-37.01-9.58-
Change in Net Working Capital
-0.77-9.57-7.21-2.941.56-
Source: S&P Capital IQ. Standard template. Financial Sources.